Exercise-induced bronchoconstriction: Burden and prevalence
Exercise-induced bronchoconstriction (EIB) is common in asthma patients as well as athletes. This article provides an overview of the prevalence and impact on quality of life (QoL) of EIB based on an analysis review of selected literature. The term EIB is preferred to exercise-induced asthma because EIB does not cause asthma, and asthma is not a prerequisite to have EIB. EIB is extremely common in asthma patients and is reported in most asthma patients. Several factors may increase the prevalence of EIB including severity of asthma, family history of asthma, atopy, respiratory infections, and urbanization. Some studies also suggest EIB is more common in girls than boys and in younger-age children. EIB also occurs in athletes, even without asthma. The prevalence of EIB varies among sports with some of the highest rates observed in Nordic combined, cross-country, and short track Winter Olympic athletes. Environmental factors may have a role in EIB including chlorine in swimmers and particulate matter exposure from fossil-fueled ice resurfacing machines in ice arena athletes. Accumulating evidence indicates that the burden of EIB impairs QoL. EIB is a common condition in asthma patients and athletes and adversely affects the QoL and the ability to participate in sports.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Document Type: Research Article
Affiliations: Division of Allergy and Immunology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA
Publication date: January 1, 2012
More about this publication?
- Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.
The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma and by having the potential to directly impact the quality of patient care. AAP welcomes the submission of original works including peer-reviewed original research and clinical trial results. Additionally, as the official journal of the Eastern Allergy Conference (EAC), AAP will publish content from EAC poster sessions as well as review articles derived from EAC lectures.
Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.
Articles marked "F" offer free full text for personal noncommercial use only.
The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
- Editorial Board
- Information for Authors
- Submit a Paper
- Information for Advertisers
- Reprint Requests
- Ingenta Connect is not responsible for the content or availability of external websites